GLP-1 Clinical Relevance #44Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Longitudinal StudyCohort StudyInsulin ResistanceChildhood ObesityPediatric PatientsEndocrinologyCardiometabolic RiskEpigenetic MarkersDNA MethylationMetabolic Health TrajectoriesPediatric Metabolic DiseaseBiomarker Discovery Why...
A Major International Cannabis Study Is Being Planned—Here Is What Researchers Intend to Find Out
Our approach will be largely data-driven, focused on untangling the effects of cannabis on mental health, either good or bad.
`Adolescent Cannabis Use & Mental Health Risk: Clinical Evidence`
Clinical Takeaway Cannabis use during adolescence is associated with increased risk of psychotic, bipolar, depressive, and anxiety disorders in large population-based longitudinal data. These findings reflect clinically diagnosed conditions, not just symptoms,...
`Endocannabinoid System & Adolescent Cannabis Use Risk`
Clinical Takeaway Adolescents with higher levels of depression and anxiety symptoms show increased likelihood of initiating and using cannabis more frequently over time, supporting the self-medication hypothesis in this age group. This...
Real-Time and Long-Term Effects of Medical Marijuana on Older Adults: Protocol for a Prospective Cohort Study.
Older adults represent the fastest-growing group of medical marijuana (MM) users in the United States, with chronic pain being the most common reason for use…
Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.
Research shows that delta-9-tetrahydrocannabinol (THC) is linked to increased anxiety, while cannabidiol (CBD) may have anxiolytic effects. Cannabis use is o…
endocannabinoid system: Cannabis Reduces Anxiety Long-Term
Clinical Takeaway Cannabis use for anxiety produced daily reductions in anxiety symptoms, but the effects varied meaningfully depending on whether participants used flower or edible products. CBD-containing products showed anxiolytic benefits, while...
Endocannabinoid System & Adolescent Health: Clinical Evidence
Clinical Takeaway Over a 15-year period, Canadian youth were tracked from adolescence into early adulthood to understand how early risk factors like body image concerns and disordered eating contribute to later mental...
Endocannabinoid System & Adolescent Health Research
Clinical Takeaway A 15-year Canadian cohort study tracked adolescents into early adulthood to examine how early risk factors like body image concerns and disordered eating patterns contribute to later eating disorders, mental...
Endocannabinoid System Research: Cannabis & Adolescent Health
Clinical Takeaway The REAL 2.0 cohort study tracked Canadian youth over 15 years to examine how adolescent risk factors like body image concerns and disordered eating influence mental health, substance use, and...